Isotechnika Pharma Inc IPHAF

Timelines

[nowayout]

Reviewing news releases from early Dec 04, I note that Yatscoff had stated as a goal to have full enrollment of the 400 patients for phase 111 psoriasis by April 05. The recent announcements of full recruitment would place them 3 months ahead on this timetable. This appears to reflect well on the company's projected timelines, and also is likely an indication of Physicians and patients eagerness to receive what is perceived a new "wonder" drug in the management of psoriasis and auto immune disease?